MARKET

BNTC

BNTC

Benitec Biopharm
NASDAQ
12.47
-0.20
-1.58%
After Hours: 12.47 0 0.00% 19:30 08/28 EDT
OPEN
12.60
PREV CLOSE
12.67
HIGH
12.76
LOW
11.71
VOLUME
103.17K
TURNOVER
--
52 WEEK HIGH
16.76
52 WEEK LOW
9.85
MARKET CAP
428.40M
P/E (TTM)
-11.2606
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BNTC last week (0817-0821)?
Weekly Report · 5d ago
Weekly Report: what happened at BNTC last week (0810-0814)?
Weekly Report · 08/17 10:00
Weekly Report: what happened at BNTC last week (0803-0807)?
Weekly Report · 08/10 09:56
Weekly Report: what happened at BNTC last week (0727-0731)?
Weekly Report · 08/03 09:56
This Crowdstrike Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Benzinga · 07/28 13:02
Benitec Biopharma Price Target Announced at $16.00/Share by Wedbush
Dow Jones · 07/28 12:59
Wedbush Initiates Coverage On Benitec Biopharma with Outperform Rating, Announces Price Target of $16
Benzinga · 07/28 12:49
Wedbush bullish on Benitec Biopharma, initiates with an Outperform
TipRanks · 07/28 11:55
More
About BNTC
Benitec Biopharma Inc is a clinical-stage biotechnology company. The Company is focused on the advancement of novel genetic medicines. Its proprietary Silence and Replace deoxyribonucleic acid (DNA) -directed ribonucleic acid (RNA) interference platform combines RNA interference, or RNAi, with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The Company is developing Silence and Replace-based therapeutics (BB-301) for chronic and life-threatening human conditions including Oculopharyngeal Muscular Dystrophy (OPMD). BB-301 is an adeno-associated viral vector (AAV)-based gene therapy designed to silence the expression of disease-causing genes (to slow, or halt, the underlying mechanism of disease progression) and to simultaneously replace the mutant genes with normal, wildtype genes.

Webull offers Benitec Biopharma Inc stock information, including NASDAQ: BNTC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BNTC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BNTC stock methods without spending real money on the virtual paper trading platform.